Suzhou Basecare Medical Corporation Limited - Laporan Laba Rugi (TTM)

Suzhou Basecare Medical Corporation Limited
HK ˙ SEHK
HK$ 3.41 ↑0.16 (4.92%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Suzhou Basecare Medical Corporation Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 71 81 90 99 103 107 117 126 133 141 149 158 183 208 228 247 273 299 287 276
Change (%) 14.13 11.09 9.99 3.52 4.58 8.58 7.90 6.04 5.70 6.02 5.68 15.87 13.69 9.42 8.61 10.51 9.51 -3.91 -4.07
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 43 53 57 61 59 56 61 66 74 81 88 95 106 117 124 132 147 163 154 144
Change (%) 24.01 6.79 6.35 -3.19 -4.35 9.21 8.43 11.19 10.06 8.38 7.73 11.38 10.22 6.38 6.00 11.93 10.66 -5.74 -6.09
% of Revenue 60.59 65.83 63.28 61.19 57.22 52.33 52.64 52.90 55.46 57.75 59.03 60.18 57.85 56.08 54.52 53.20 53.89 54.46 53.42 52.29
Gross Operating Profit 28 28 33 38 44 51 55 59 59 60 61 63 77 91 104 116 126 136 134 132
Change (%) -1.05 19.40 16.25 14.10 16.54 7.88 7.31 0.27 0.27 2.81 2.73 22.65 18.46 13.31 11.74 8.89 8.16 -1.72 -1.75
% of Revenue 39.41 34.17 36.72 38.81 42.78 47.67 47.36 47.10 44.54 42.25 40.97 39.82 42.15 43.92 45.48 46.80 46.11 45.54 46.58 47.71
SG&A 26 42 61 80 101 115 122 129 145 161 169 176 193 209 237 265 271 276 274 272
Change (%) 62.94 45.38 31.22 26.57 13.42 6.07 5.72 12.81 11.36 4.42 4.23 9.54 8.71 13.26 11.71 2.18 2.14 -0.72 -0.72
% of Revenue 36.15 51.61 67.54 80.57 98.51 106.84 104.37 102.26 108.79 114.62 112.88 111.34 105.25 100.64 104.17 107.14 99.07 92.40 95.48 98.81
R&D 27 34 39 44 61 74 85 96 108 120 129 138 134 130 133 135 135 135 129 122
Change (%) 25.53 13.60 11.98 38.56 21.28 15.40 13.35 12.11 10.80 7.60 7.06 -3.05 -3.14 2.28 2.23 -0.08 -0.08 -4.74 -4.98
% of Revenue 38.65 42.51 43.47 44.26 59.24 68.70 73.01 76.70 81.09 85.01 86.27 87.40 73.13 62.30 58.23 54.81 49.56 45.22 44.83 44.41
OpEx 100 135 161 186 219 240 265 290 323 357 379 401 425 450 488 526 546 567 550 533
Change (%) 34.79 18.88 15.88 17.67 9.37 10.47 9.48 11.57 10.37 6.21 5.85 6.03 5.68 8.47 7.81 3.91 3.76 -3.02 -3.11
% of Revenue 141.14 166.69 178.36 187.92 213.59 223.38 227.27 230.59 242.60 253.33 253.77 254.16 232.58 216.20 214.32 212.74 200.03 189.53 191.29 193.19
Operating Income -29 -54 -71 -87 -117 -132 -148 -164 -190 -216 -230 -243 -243 -242 -260 -279 -273 -268 -262 -257
Change (%) 85.02 30.54 23.40 33.75 13.59 12.00 10.71 15.80 13.65 6.33 5.95 -0.35 -0.36 7.65 7.11 -1.95 -1.99 -2.03 -2.07
% of Revenue -41.14 -66.69 -78.36 -87.92 -113.59 -123.38 -127.27 -130.59 -142.60 -153.33 -153.77 -154.16 -132.58 -116.20 -114.32 -112.74 -100.03 -89.53 -91.29 -93.19
Interest Expense -2 -1 -1 -1 -1 -1 -1 -1 -1 -0 -0 -0 -1 -3 -4 -6 -8 -9 -11 -13
Change (%) -3.66 -2.75 -2.83 -6.22 -3.41 -11.03 -12.40 -24.75 -32.88 -34.58 -52.85 802.94 88.93 68.85 40.78 25.53 20.34 18.64 15.71
% of Revenue -2.15 -1.81 -1.59 -1.40 -1.27 -1.17 -0.96 -0.78 -0.55 -0.35 -0.22 -0.10 -0.76 -1.25 -1.94 -2.51 -2.85 -3.13 -3.87 -4.67
Net Income -1,014 -877 -494 -112 -119 -144 -133 -123 -123 -123 -143 -163 -177 -192 -221 -250 -244 -237 -238 -239
Change (%) -13.53 -43.62 -77.36 5.90 21.18 -7.24 -7.81 -0.07 -0.07 16.34 14.04 8.89 8.16 15.27 13.25 -2.64 -2.71 0.33 0.33
% of Revenue -1,427.31 -1,081.33 -548.79 -112.95 -115.54 -133.88 -114.37 -97.72 -92.09 -87.06 -95.53 -103.08 -96.88 -92.17 -97.09 -101.24 -89.20 -79.25 -82.74 -86.54

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista